Hamel Associates’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.04M Sell
185,294
-2,094
-1% -$45.7K 1.11% 34
2026
Q1
$4.1M Buy
187,388
+24,432
+15% +$539K 1.17% 33
2025
Q4
$3.6M Buy
162,956
+53,181
+48% +$1.18M 1.08% 35
2025
Q3
$2.43M Sell
109,775
-2,805
-2% -$61.7K 0.75% 41
2025
Q2
$2.47M Buy
112,580
+3,475
+3% +$75.3K 0.84% 40
2025
Q1
$2.37M Sell
109,105
-70,464
-39% -$1.51M 0.81% 43
2024
Q4
$3.84M Buy
179,569
+90,059
+101% +$1.95M 1.23% 30
2024
Q3
$1.98M Buy
89,510
+27,785
+45% +$606K 0.61% 45
2024
Q2
$1.31M Buy
+61,725
New +$1.3M 0.41% 49

Other funds holding IBDV

Hamel Associates's IBDV Position: Q2 2026 in Review

Hamel Associates reduced its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 1.1% in Q2 2026, selling an estimated $45.7K and leaving 185,294 shares worth $4.04M. The position accounts for 1.11% of the portfolio, ranked #34.

Hamel Associates first reported a position in IBDV in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.1M in Q1 2026. 177 funds tracked by Wall St. Rank hold IBDV as of Q2 2026.

  • Hamel Associates held 185,294 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $4.04M as of Q2 2026.
  • Hamel Associates sold 2,094 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2026, an estimated $45.7K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 1.11% of Hamel Associates's portfolio in Q2 2026, its #34 holding.
  • Hamel Associates first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q2 2024 and has held it in 9 quarters since.
  • Hamel Associates's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $4.1M in Q1 2026.
  • 177 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2026.

Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.